Stay updated on Tislelizumab vs Sorafenib in Unresectable HCC Clinical Trial

Sign up to get notified when there's something new on the Tislelizumab vs Sorafenib in Unresectable HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tislelizumab vs Sorafenib in Unresectable HCC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision updated from v3.6.3 to v3.6.4, reflecting a small internal update to the page rendering. No visible study details or user-facing content were changed.
    Difference
    0.0%
    Check dated 2026-07-25T13:25:44.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.6.3, indicating a minor platform/template update for the study record page.
    Difference
    0.0%
    Check dated 2026-07-03T23:23:43.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The page's revision was updated from v3.6.0 to v3.6.2, signaling a backend/frontend update to the listing without modifying the study information.
    Difference
    0.0%
    Check dated 2026-06-27T00:12:46.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Recruitment status updated to 'No longer looking for participants' and new help sections were added (How to Read a Study Record, Common Questions, How to Join a Study). The Intervention/Treatment heading was updated and the page revision shows v3.6.0.
    Difference
    0.2%
    Check dated 2026-06-12T16:28:46.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    The page’s revision badge shows v3.5.5, replacing the previous v3.5.4. This appears to be a minor, system-level update (software/documentation version) rather than a change to study content or functionality.
    Difference
    0.0%
    Check dated 2026-06-05T11:36:14.000Z thumbnail image
  9. Check
    81 days ago
    Change Detected
    Summary
    Revision: v3.5.4 replaces the previous v3.5.3 label, signaling a backend or UI update unrelated to study details.
    Difference
    0.0%
    Check dated 2026-05-15T02:14:54.000Z thumbnail image

Stay in the know with updates to Tislelizumab vs Sorafenib in Unresectable HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tislelizumab vs Sorafenib in Unresectable HCC Clinical Trial page.